The Globalization of Takeda and the Challenges of Developing Global Leaders from Japan

Date: Wednesday, November 8, 2017
Time: 12:00 - 14:00
​Venue: ANA InterContinental Tokyo, B1, Galaxy Room
Speakers:
1. Yasuchika Hasegawa
Corporate Counselor, 
​Takeda Pharmaceutical Company Ltd.; Chairman of the Board and President, Institute for Strategic Leadership (ISL); 
Chair of the Board of Counselors, Graduate School of Leadership and Innovation, 
Shizenkan University; Former Chair of Keizai Doyukai;
2. Dr. Tomoyoshi (Tomo) Noda
Founder, Institute for Strategic Leadership; Founder and Chair, Shizenkan University
Hosting Committee: CEO Forum
Member Fee: ¥7,900
Guest Fee: ¥9,900
Meal: Plated Lunch
Registration/Cancellation Deadline: Thursday, November 2, 17:00

SIGN UP

---

Event Overview:

The 2017 CEO Forum is pleased to host a luncheon event with special guests, Mr. Yasuchika Hasegawa and Dr. Tomoyoshi Noda. Well-known for his leadership as President of Takeda Pharmaceutical Company Ltd., Mr. Hasegawa will share a behind-the-scenes account of his experience leading the largest-ever cross-border takeover by a Japanese pharmaceutical company and discuss the challenges of transforming the company from a domestic drug maker to a global biopharma player. Mr. Hasegawa’s story will shed light on business and leadership issues that extend beyond industry-specific topics.

The event will include a discussion by Mr. Hasegawa and ISL Founder Dr. Noda on their efforts to shape the next generation of business leaders at Shizenkan Graduate School of Leadership and Innovation, which focuses on developing whole-person business leaders to lead organizational transformation and innovation with creativity, willpower and character.

For more information about Mr. Hasegawa and Dr. Noda, please click here.

Best regards,
Sarah Casanova, Harry Hill, Co-chairs
CEO Forum
The American Chamber of Commerce in Japan

NOTE 1: This event is OFF THE RECORD.
NOTE 2: If you cancel after the stated deadline, the full meeting fee will be charged to your account. Sorry, no substitutions or walk-ins. ​